Divi's Laboratories Limited
DIVISLAB
주식 순위
#907
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
주가
$100.28
마지막 동기화: 2026-10-19
시가총액
$26.62B
변동 (1일)
-0.41%
변동 (1년)
33.45%
국가
IN
거래 Divi's Laboratories Limited (DIVISLAB)
카테고리
Healthcare
Divi's Laboratories Limited (DIVISLAB)의 매출
Jun 2026 기준 매출 TTM: $1.24B
Divi's Laboratories Limited의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.24B입니다. 2024년에 회사는 $934.96M의 수익을 올렸으며 이는 2023년의 $942.90M 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Divi's Laboratories Limited의 수익 기록 (2005 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.24B | 13.27% |
| 2025 | $1.09B | 17.03% |
| 2024 | $934.96M | -0.84% |
| 2023 | $942.90M | -18.66% |
| 2022 | $1.16B | 23.73% |
| 2021 | $936.88M | 33.39% |
| 2020 | $702.35M | 0.99% |
| 2019 | $695.47M | 16.36% |
| 2018 | $597.68M | -4.38% |
| 2017 | $625.04M | 9.65% |
| 2016 | $570.02M | 14.19% |
| 2015 | $499.20M | 18.17% |
| 2014 | $422.45M | 7.02% |
| 2013 | $394.74M | 7.38% |
| 2012 | $367.61M | 24.43% |
| 2011 | $295.42M | 40.91% |
| 2010 | $209.66M | -9.82% |
| 2009 | $232.50M | -90.99% |
| 2008 | $2.58B | 1,444.12% |
| 2007 | $167.15M | 95.34% |
| 2006 | $85.57M | 7.56% |
| 2005 | $79.55M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 433.49% |
IN
|
